ArticleFrontiers in endocrinology2026

Incidence and risk factors of tocilizumab-induced hypofibrinogenemia in patients with thyroid eye disease: a single-center retrospective study.

Ente Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.